Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Partners with TGen to Develop CGH Arrays for Cancer Research

NEW YORK, June 8 (GenomeWeb News) - Agilent Technologies and the Translational Genomics Research Institute have begun a collaboration to develop microarrays for use in comparative genomic hybridization (CGH) for cancer research, Agilent said today.


Agilent said that the collaboration will speed its development of commercial CGH microarrays, which could be used to screen tumors for genetic changes. Array-based CGH methods that "pinpoint the precise boundaries" of these changes "are not widely available today," the company said.


Agilent Laboratories, the central research facility of Agilent Technologies, is collaborating with TGen to "benchmark and optimize" the CGH arrays, which TGen is using under an early-access agreement, the company said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.